Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Ravindran

Showing results (231-240 of 252) with videos related to

Pageof 26
Sort By:
Psychiatry Research|April 23, 2022
Pain severity and pain interference during major depressive episodes treated with escitalopram and aripiprazole adjunctive therapy: a CAN-BIND-1 reportCalvin Diep, Norma Rosenek, Yuelee Khoo, et al.
Evidence-Based Mental Health|October 2, 2021
Comparative efficacy and acceptability of psychotherapies for post-traumatic stress disorder in children and adolescents: a systematic review and network meta-analysisYajie Xiang, Andrea Cipriani, Teng Teng, et al.
The Journal of Clinical Psychiatry|June 20, 2020
Symptom Dimension of Interest-Activity Indicates Need for Aripiprazole Augmentation of Escitalopram in Major Depressive Disorder: A CAN-BIND-1 ReportRudolf Uher, Benicio N Frey, Lena C Quilty, et al.
Journal of Affective Disorders|October 28, 2021
Association between discrepancy in objective and subjective cognitive abilities and treatment response in patients with major depressive disorder: A CAN-BIND-1 study reportKaterina Rnic, Young-Eun Jung, Ivan Torres, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|May 21, 2026
An Individual Participant Data Analysis: Optimizing Pharmacological Treatment in Children and Adolescents With Major Depressive DisorderYajie Xiang, Pim Cuijpers, Wei Li, et al.
Molecular Psychiatry|July 25, 2023
Epidemiology, clinical presentation, pathophysiology, and management of long COVID: an updateSizhen Su, Yimiao Zhao, Na Zeng, et al.
Lancet (London, England)|June 13, 2016
Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysisAndrea Cipriani, Xinyu Zhou, Cinzia Del Giovane, et al.
Innovations in Clinical Neuroscience|December 16, 2016
The Depression Inventory Development Workgroup: A Collaborative, Empirically Driven Initiative to Develop a New Assessment Tool for Major Depressive DisorderAnthony L Vaccarino, Kenneth R Evans, Amir H Kalali, et al.
The Lancet. Psychiatry|June 22, 2020
Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysisXinyu Zhou, Teng Teng, Yuqing Zhang, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 4, 2016
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological TreatmentsSidney H Kennedy, Raymond W Lam, Roger S McIntyre, et al.
Pageof 26

Showing results (231-240 of 252) with videos related to

Sort By:
Pageof 26
Psychiatry Research|April 23, 2022
Pain severity and pain interference during major depressive episodes treated with escitalopram and aripiprazole adjunctive therapy: a CAN-BIND-1 reportCalvin Diep, Norma Rosenek, Yuelee Khoo, et al.
Evidence-Based Mental Health|October 2, 2021
Comparative efficacy and acceptability of psychotherapies for post-traumatic stress disorder in children and adolescents: a systematic review and network meta-analysisYajie Xiang, Andrea Cipriani, Teng Teng, et al.
The Journal of Clinical Psychiatry|June 20, 2020
Symptom Dimension of Interest-Activity Indicates Need for Aripiprazole Augmentation of Escitalopram in Major Depressive Disorder: A CAN-BIND-1 ReportRudolf Uher, Benicio N Frey, Lena C Quilty, et al.
Journal of Affective Disorders|October 28, 2021
Association between discrepancy in objective and subjective cognitive abilities and treatment response in patients with major depressive disorder: A CAN-BIND-1 study reportKaterina Rnic, Young-Eun Jung, Ivan Torres, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|May 21, 2026
An Individual Participant Data Analysis: Optimizing Pharmacological Treatment in Children and Adolescents With Major Depressive DisorderYajie Xiang, Pim Cuijpers, Wei Li, et al.
Molecular Psychiatry|July 25, 2023
Epidemiology, clinical presentation, pathophysiology, and management of long COVID: an updateSizhen Su, Yimiao Zhao, Na Zeng, et al.
Lancet (London, England)|June 13, 2016
Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysisAndrea Cipriani, Xinyu Zhou, Cinzia Del Giovane, et al.
Innovations in Clinical Neuroscience|December 16, 2016
The Depression Inventory Development Workgroup: A Collaborative, Empirically Driven Initiative to Develop a New Assessment Tool for Major Depressive DisorderAnthony L Vaccarino, Kenneth R Evans, Amir H Kalali, et al.
The Lancet. Psychiatry|June 22, 2020
Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysisXinyu Zhou, Teng Teng, Yuqing Zhang, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 4, 2016
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological TreatmentsSidney H Kennedy, Raymond W Lam, Roger S McIntyre, et al.
Pageof 26